Cell-free DNA Levels in Cellulitis: A Cross-sectional Prospective Study
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0020Keywords:
cellulitis, cell-free DNA, biomarkerAbstract
Cellulitis is a prevalent inflammatory dermatosis caused by bacterial infection that lacks a definitive quantitative biomarker for assessing disease activity and monitoring therapeutic response, leading to diagnostic ambiguity and management challenges. Cell-free DNA (cfDNA), consisting of short nucleic acid fragments released into circulation from necrotic and apoptotic cells, represents a potential objective measure of systemic inflammation. We hypothesized that cfDNA levels would be elevated in patients with cellulitis and correlate with established inflammatory parameters and clinical outcomes. We conducted a cross-sectional prospective study of 36 patients with confirmed cellulitis and 30 healthy controls. Plasma cfDNA levels were quantified at baseline (admission), 72 hours after antibiotic initiation, at discharge, and at 3-week follow-up. We assessed correlations between cfDNA and traditional inflammatory markers, including C-reactive protein (CRP) and white blood cell (WBC) counts, as well as patient-reported pain scores. Patients with cellulitis exhibited significantly elevated plasma cfDNA levels at admission compared with healthy controls. Following antibiotic therapy, cfDNA levels declined rapidly and were positively correlated with reductions in WBCwhite blood cell/neutrophil counts. Higher cfDNA levels were also associated with increased subjective pain scores. These findings suggest that cfDNA may serve as a promising biomarker for the diagnosis of cellulitis and for objectively monitoring treatment efficacy, with potential utility as an objective proxy for pain severity.
Downloads
References
Yu Weng Q, Raff AB, Vedak P, Cohen JM, Okhovat JP. The health care burden of misdiagnosed cellulitis: an inpatient analysis. J Am Acad Dermatol 2016; 74: AB74. DOI: https://doi.org/10.1016/j.jaad.2016.02.292
Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol 2017; 153: 141–146. DOI: https://doi.org/10.1001/jamadermatol.2016.3816
Bertolus C, Schouman T, Aubry A, Hausfater P. Is procalcitonin a useful biomarker for the risk stratification of facial cellulitis? J Craniomaxillofac Surg 2016; 44: 995–997. DOI: https://doi.org/10.1016/j.jcms.2016.05.023
Brindle RJ, Ijaz A, Davies P. Procalcitonin and cellulitis: correlation of procalcitonin blood levels with measurements of severity and outcome in patients with limb cellulitis. Biomarkers 2019; 24: 127–130. DOI: https://doi.org/10.1080/1354750X.2018.1501764
Erturk A, Cure MC, Cure E, Kurt A, Cicek AC, Yuce S. Clinical potential of resistin as a novel prognostic biomarker for cellulitis. Exp Ther Med 2015; 9: 1875–1880. DOI: https://doi.org/10.3892/etm.2015.2311
Ang T, Juniat V, Shapira Y, Selva D. Systemic inflammatory markers differentiate between orbital cellulitis and non-specific orbital inflammation. Orbit 2023; 42: 245–250. DOI: https://doi.org/10.1080/01676830.2022.2087233
González-Jiménez P, Méndez R, Latorre A, Piqueras M, Balaguer-Cartagena MN, Moscardó A, et al. Neutrophil extracellular traps and platelet activation for identifying severe episodes and clinical trajectories in COVID-19. Int J Mol Sci 2023; 24: 6690. DOI: https://doi.org/10.3390/ijms24076690
Valpione S, Gremel G, Mundra P, Middlehurst P, Galvani E, Girotti MR, et al. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. Eur J Cancer 2018; 88: 1–9. DOI: https://doi.org/10.1016/j.ejca.2017.10.029
Eichenberger EM, de Vries CR, Ruffin F, Sharma-Kuinkel B, Park L, Hong D, et al. Microbial cell-free DNA identifies etiology of bloodstream infections, persists longer than conventional blood cultures, and its duration of detection is associated with metastatic infection in patients with Staphylococcus aureus and gram-negative bacteremia. Clin Infect Dis 2022; 74: 2020–2027. DOI: https://doi.org/10.1093/cid/ciab742
Jing Q, Leung CHC, Wu AR. Cell-free DNA as biomarker for sepsis by integration of microbial and host information. Clin Chem 2022; 68: 1184–1195. DOI: https://doi.org/10.1093/clinchem/hvac097
De Luca G, Lev PR, Camacho MF, Goette NP, Sackmann F, Castro Ríos MA, et al. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis. Front Immunol 2023; 14: 1161832. DOI: https://doi.org/10.3389/fimmu.2023.1161832
Urosevic N, Merritt AJ, Inglis TJJ. Plasma cfDNA predictors of established bacteraemic infection. Access Microbiol 2022; 4: acmi000373. DOI: https://doi.org/10.1099/acmi.0.000373
Johnston DGW, Hambly R, Kearney N, Tobin DJ, Kirby B. Cell-free DNA is elevated in the serum of patients with hidradenitis suppurativa. J Dermatol 2023; 50: 271–273. DOI: https://doi.org/10.1111/1346-8138.16676
Ishino T, Myangat TM, Sawamura S, Kajihara I, Shimada S, Kanemaru H, et al. Elevation of cell-free DNA in patients with clinically amyopathic dermatomyositis. J Dermatol 2023; 50: e189–e191. DOI: https://doi.org/10.1111/1346-8138.16714
Gray ES, Rizos H, Reid AL, Boyd SC, Pereira MR, Lo J, et al. Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget 2015; 6: 42008–42018. DOI: https://doi.org/10.18632/oncotarget.5788
Coimbra S, Catarino C, Costa E, Oliveira H, Figueiredo A, Rocha-Pereira P, et al. Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy. Br J Dermatol 2014; 170: 939–942. DOI: https://doi.org/10.1111/bjd.12738
Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem 2009; 46: 488–494. DOI: https://doi.org/10.1258/acb.2009.009002
Fleckenstein J, Neuberger EWI, Bormuth P, Comes F, Schneider A, Banzer W, et al. Investigation of the sympathetic regulation in delayed onset muscle soreness: results of an RCT. Front Physiol 2021; 12: 697335. DOI: https://doi.org/10.3389/fphys.2021.697335
Kostyuk SV, Porokhovnik LN, Ershova ES, Malinovskaya EM, Konkova MS, Kameneva LV, et al. Changes of KEAP1/NRF2 and IKB/NF-κB expression levels induced by cell-free DNA in different cell types. Oxid Med Cell Longev 2018; 2018: 1052413. DOI: https://doi.org/10.1155/2018/1052413
Kanngiesser M, Häussler A, Myrczek T, Küsener N, Lim HY, Geisslinger G, et al. Inhibitor kappa B kinase beta dependent cytokine upregulation in nociceptive neurons contributes to nociceptive hypersensitivity after sciatic nerve injury. J Pain 2012; 13: 485–497. DOI: https://doi.org/10.1016/j.jpain.2012.02.010
Roth S, Wernsdorf SR, Liesz A. The role of circulating cell-free DNA as an inflammatory mediator after stroke. Semin Immunopathol 2023; 45: 411–425. DOI: https://doi.org/10.1007/s00281-023-00993-5
Lacagnina MJ, Watkins LR, Grace PM. Toll-like receptors and their role in persistent pain. Pharmacol Ther 2018; 184: 145–158. DOI: https://doi.org/10.1016/j.pharmthera.2017.10.006
Hu Y, Chen Y, Liu T, Zhu C, Wan L, Yao W. The bidirectional roles of the cGAS-STING pathway in pain processing: cellular and molecular mechanisms. Biomed Pharmacother 2023; 163: 114869. DOI: https://doi.org/10.1016/j.biopha.2023.114869
Lo YMD, Zhang J, Leung TN, Lau TK, Chang AMZ, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Human Genet 1999; 64: 218–224. DOI: https://doi.org/10.1086/302205
Halpern D, Cohen A, Sharon N, Krieger Y, Silberstein E, Michael T, et al. Admission circulating cell-free DNA levels as a prognostic factor in pediatric burns. Biomed Res Int 2022; 2022: 5004282. DOI: https://doi.org/10.1155/2022/5004282
Rhodes A, Cecconi M. Cell-free DNA and outcome in sepsis. Crit Care 2012; 16: 170. DOI: https://doi.org/10.1186/cc11508
Gordon CB, Zenaty Y, Ollech A, Test G, Douvdevani A, Horev A. Cell-free DNA levels in herpes zoster: a cross-sectional longitudinal study. Acta Derm Venereol 2025; 105: adv42137. DOI: https://doi.org/10.2340/actadv.v105.42137
Yadav K, Krzyzaniak N, Alexander C, Scott AM, Clark J, Glasziou P, et al. The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a systematic review and meta-analysis. Infection 2022; 50: 859–871. DOI: https://doi.org/10.1007/s15010-022-01842-7
Bruun T, Oppegaard O, Hufthammer KO, Langeland N, Skrede S. Early response in cellulitis: a prospective study of dynamics and predictors. Clin Infect Dis 2016; 63: 1034–1041. DOI: https://doi.org/10.1093/cid/ciw463
van ’t Erve I, Medina JE, Leal A, Papp E, Phallen J, Adleff V, et al. Metastatic colorectal cancer treatment response evaluation by ultra-deep sequencing of cell-free DNA and matched white blood cells. Clin Cancer Res 2023; 29: 899–909. DOI: https://doi.org/10.1158/1078-0432.CCR-22-2538
Fernandez-Garcia D, Hills A, Page K, Hastings RK, Toghill B, Goddard KS, et al. Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer. Breast Cancer Res 2019; 21: 149. DOI: https://doi.org/10.1186/s13058-019-1235-8
Syeda MM, Wiggins JM, Corless BC, Long GV, Flaherty KT, Schadendorf D, et al. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. Lancet Oncol 2021; 22: 370–380. DOI: https://doi.org/10.1016/S1470-2045(20)30726-9
García-Escobar A, Vera-Vera S, Tébar-Márquez D, Rivero-Santana B, Jurado-Román A, Jiménez-Valero S, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: new insights for a potential predictor of anti-cytokine therapy responsiveness. Microvasc Res 2023; 150: 104598. DOI: https://doi.org/10.1016/j.mvr.2023.104598
Yuwono NL, Warton K, Ford CE. The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma. Elife 2021; 10: e69679. DOI: https://doi.org/10.7554/eLife.69679
Yao W, Mei C, Nan X, Hui L. Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study. Gene 2016; 590: 142–148. DOI: https://doi.org/10.1016/j.gene.2016.06.033
Plebani M. Why C-reactive protein is one of the most requested tests in clinical laboratories? Clin Chem Lab Med CCLM 2023; 61: 1540–1545. DOI: https://doi.org/10.1515/cclm-2023-0086
Whitaker CM, Low S, Gorbachova T, Raphael JS, Williamson C. Imaging and laboratory workup for hand infections. Hand Clin 2020; 36: 285–299. DOI: https://doi.org/10.1016/j.hcl.2020.03.002
Brindle R, Davies P. Procalcitonin and cellulitis: cohort study of the correlation of procalcitonin blood levels with the severity and outcome in patients with limb cellulitis. Open Forum Infect Dis 2016; 3: 231. DOI: https://doi.org/10.1093/ofid/ofw172.98
Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011; 9: 107. DOI: https://doi.org/10.1186/1741-7015-9-107
Nesselbush MC, Luca BA, Jeon YJ, Jabara I, Meador CB, Garofalo A, et al. An ultrasensitive method for detection of cell-free RNA. Nature New Biol 2025; 641: 759–768. DOI: https://doi.org/10.1038/s41586-025-08834-1
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
